COVID-19: Epidemiological Update for September 22, 2022

Key Points

In Week 37, the spread of SARS-CoV-2 accelerated across the entire mainland, with virological indicators showing a sharp increase.

  • Mainland France:

    • Marked increase in the incidence rate across the entire territory

    • Rise in the incidence rate driven primarily by those under 20 and those aged 30–49 (over 50%)

    • Hospital indicators have stabilized at the national level, with regional disparities

  • Overseas territories:

    • Incidence rates are declining in most regions except Martinique

Variants

  • Omicron sublineages: BA.5 ubiquitous, accounting for 93% of sequences in the Flash S36 survey (09/05)

Prevention

  • Vaccination as of September 19, 2022 (Covid Vaccine data):

    • 74.3% of those aged 18 and older and 82.4% of those aged 65 and older have received their first booster dose

    • 28.7% of those aged 60–79 (34.2% of those eligible based on the time since their last dose) and 36.4% of those aged 80 and older (47.8% of those eligible) have received their second booster dose

  • Given the accelerating spread of SARS-CoV-2, adherence to combined measures remains necessary:

    • up-to-date COVID-19 vaccination, particularly the second booster dose for vulnerable individuals;

    • isolation in the event of a positive COVID-19 test and/or symptoms;

    • continued adherence to preventive measures, including mask-wearing—particularly around at-risk individuals or in crowded indoor settings (such as public transportation or large gatherings)—as well as handwashing and ventilation of enclosed spaces.

In relation to

Our latest news

news

2026 “Sexual Behavior” Survey (ERAS) for men who have sex with men

news

Hervé Maisonneuve has been appointed scientific integrity officer for a...

Visuel illustratif

news

Public Health France 2026 Barometer: Launch of the Survey